|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 005 |
20211105082603.0 |
| 008 |
131113s2014 nyu b 001 0 eng d |
| 010 |
|
|
|a 2013045533
|
| 011 |
|
|
|a BIB MATCHES WORLDCAT
|
| 020 |
|
|
|a 019993780X
|q alk. paper
|
| 020 |
|
|
|a 9780199937806
|q alk. paper
|
| 035 |
|
|
|a (ATU)b13685922
|
| 035 |
|
|
|a (OCoLC)863383107
|
| 040 |
|
|
|a DNLM/DLC
|b eng
|e rda
|c DLC
|d YDX
|d NLM
|d YDXCP
|d BTCTA
|d BDX
|d UKMGB
|d OCLCO
|d ATU
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
4 |
|a RJ53.N48
|b T74 2014
|
| 082 |
0 |
0 |
|a 618.9280475
|2 23
|
| 245 |
0 |
0 |
|a Treatments of neurodevelopmental disorders :
|b targeting neurobiological mechanisms /
|c edited by Randi Jenssen Hagerman and Robert L. Hendren.
|
| 264 |
|
1 |
|a New York :
|b Oxford University Press,
|c [2014]
|
| 264 |
|
4 |
|c ©2014
|
| 300 |
|
|
|a xvii, 376 pages ;
|c 25 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Overview of neurodevelopmental processes and the assessment of patients with neurodevelopmental disorders / Robert Hendren, Andre Goldani, Randi Hagerman -- Autism : neurobiologic mechanisms and targeted treatments / Robert Hendren and Randi Hagerman -- Targeted treatments in schizophrenia / Danielle A. Schlosser, Coleman Garrett, Sophia Vinogradov -- Neurodevelopmental and neurobiological aspects of major depressive disorder : from theory to therapy / Blake Rawdin, Daniel Lindqvist, Nicole Bush, Steven Hamilton, Ruhel Boparai, Scott Mackin, Victor I. Reus, Synthia H. Mellon, Owen M. Wolkowitz -- Attention deficit hyperactivity disorder / Kyle J. Rutledge, Khyati Brahmbhatt, Julie Schweitzer -- Targeted treatments in Rett syndrome / Daniel C. Tarquinio, Walter E. Kaufmann -- Cardio-facio-cutaneous syndrome and other RASopathies : prospects for treatment / William E. Tidyman and Katherine A. Rauen -- Targeted treatments in tuberous sclerosis complex (TSC) / Petrus J. de Vries -- Treatment of fragile X syndrome and fragile X-associated disorders / Reymundo Lozano, Emma B. Hare, Randi J. Hagerman -- Angelman syndrome / Mary Jacena Leigh, Lindsey Partington, Edwin Weeber -- Pharmacotherapy for cognitive enhancement in down syndrome / Aarti Ruparelia, David Patterson, William C. Mobley -- Targeted treatments for phenylketonuria / Billur Moghaddam -- Muscular dystrophies : diagnosis and new treatments / Bethany M. Lipa, Que T. Nguyen, Jay J. Han -- Translating treatments from the laboratory to the clinic / Randi Hagerman, Billur Mogahadam, Jan Nolta, Maria Diez, Robert Hendren.
|
| 650 |
|
0 |
|a Neurodevelopmental treatment
|9 338627
|
| 650 |
|
0 |
|a Nervous system
|x Diseases.
|9 321364
|
| 650 |
|
0 |
|a Mental illness
|9 320741
|
| 650 |
|
0 |
|a Mental illness
|x Treatment
|9 320745
|
| 650 |
|
0 |
|a Developmental disabilities
|x Treatment
|9 700025
|
| 650 |
|
2 |
|a Nervous System Diseases
|x pathology
|9 360312
|
| 650 |
|
2 |
|a Nervous System Diseases
|x therapy
|9 361901
|
| 650 |
|
2 |
|a Child
|9 362769
|
| 700 |
1 |
|
|a Hagerman, Randi Jenssen,
|d 1949-
|e editor.
|9 463804
|
| 700 |
1 |
|
|a Hendren, Robert L.,
|d 1949-
|e editor.
|9 292718
|
| 907 |
|
|
|a .b13685922
|b 28-09-17
|c 28-10-15
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 618_928047500000000_TRE
|7 0
|9 364645
|a N
|b N
|c nmain
|d 2015-10-29
|g 82.19
|i i13409001
|l 2
|m 3
|o 618.9280475 TRE
|p A527525B
|r 2022-11-19 00:00:00
|s 2022-10-26
|t 1
|v 82.19
|w 2021-10-31
|y B
|
| 998 |
|
|
|a (2)b
|a (2)n
|b 06-04-16
|c m
|d a
|e -
|f eng
|g nyu
|h 0
|
| 945 |
|
|
|a 618.9280475 TRE
|g 1
|i A527525B
|j 0
|l nmain
|o -
|p $82.19
|q -
|r -
|s -
|t 0
|u 1
|v 0
|w 0
|x 0
|y .i13409001
|z 29-10-15
|
| 942 |
|
|
|c B
|
| 999 |
|
|
|c 1275564
|d 1275564
|
